What does a progesterone level of 1.2 ng/mL indicate in the mid‑luteal phase, and how should luteal phase support be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A Progesterone Level of 1.2 ng/mL Indicates Anovulation or Severe Luteal Phase Deficiency

A mid-luteal progesterone level of 1.2 ng/mL (approximately 3.8 nmol/L) is abnormally low and indicates either anovulation or severe corpus luteum dysfunction requiring immediate investigation and treatment.

What This Level Means

Your progesterone level is critically low. According to established guidelines, mid-luteal progesterone levels below 6 nmol/L (approximately 1.9 ng/mL) indicate anovulation 1. Your level of 1.2 ng/mL falls well below even this threshold, suggesting you likely did not ovulate this cycle, or if you did, your corpus luteum is severely dysfunctional.

To put this in context:

  • Normal ovulatory cycles: Progesterone should be >10 ng/mL (>32 nmol/L) in mid-luteal phase 2, 3
  • Adequate luteal function: Minimum 10 ng/mL, ideally 12-13 ng/mL mean over 4 days 3
  • Inadequate luteal phase: <10 ng/mL but detectable 4
  • Your level (1.2 ng/mL): Consistent with anovulation or near-complete luteal failure

Research demonstrates that cycles with progesterone levels this low (detectable but <10 ng/mL) represent luteinization without actual ovulation in the vast majority of cases 2. In one study, only 1 of 11 cycles with progesterone below 32 nmol/L showed evidence of true ovulation on ultrasound.

Immediate Diagnostic Steps

You need to determine the underlying cause:

  1. Confirm timing: Verify this blood draw was truly mid-luteal phase (approximately 7 days after suspected ovulation, or day 21 of a 28-day cycle). If timing was off, repeat the test.

  2. Investigate common causes 1:

    • Polycystic Ovary Syndrome (PCOS): Check LH/FSH ratio (>2 suggests PCOS), testosterone (>2.5 nmol/L), and consider pelvic ultrasound
    • Hypothalamic amenorrhea: Check LH (<7 IU/mL suggests this), assess for excessive exercise, low body weight, or stress
    • Hyperprolactinemia: Measure morning prolactin (>20 μg/L is abnormal)
    • Thyroid dysfunction: Check TSH and free T4
  3. Track menstrual patterns: Document cycle length for 6 months. Cycles <23 days (polymenorrhea) or >35 days (oligomenorrhea) confirm ovulatory dysfunction.

Management of Luteal Phase Support

If You're Trying to Conceive:

Treatment depends on whether you're having recurrent pregnancy loss or just trying to conceive:

  • For recurrent miscarriage with documented luteal phase defect: Progesterone supplementation has proven benefit. Use either:

    • Vaginal micronized progesterone: 200 mg daily or twice daily until 12 weeks of pregnancy 5
    • Oral dydrogesterone: 10 mg twice daily 6
    • Intramuscular progesterone: 250 mg twice weekly 6
  • For infertility without prior pregnancy loss: First address the underlying cause of anovulation rather than simply supplementing progesterone. Treatment with clomiphene citrate or letrozole to induce ovulation is more appropriate than progesterone supplementation alone 7.

If You're Not Trying to Conceive:

With progesterone this low, you're at risk for endometrial hyperplasia from unopposed estrogen exposure. You need:

  • Cyclic progestin therapy: Take a progestogen for 10-12 days per month to protect your endometrium 8. Options include:
    • Medroxyprogesterone acetate 5-10 mg for 10-12 days/month
    • Micronized progesterone 200 mg for 10-12 days/month
    • Norethindrone acetate 5 mg for 10-12 days/month

Critical Timing Considerations:

If you do become pregnant and are receiving progesterone supplementation, continue treatment only until 12 weeks of gestation, not 16 weeks as some older guidelines suggest 5. The beneficial effects of progesterone are complete by 12 weeks when the placenta takes over progesterone production, and prolonged treatment beyond this point lacks evidence and carries theoretical risks to offspring.

Common Pitfalls to Avoid

  1. Don't assume a single low progesterone level means permanent infertility: Even normal women occasionally have anovulatory cycles (up to 30%) 3. Repeat testing in subsequent cycles is essential.

  2. Don't supplement progesterone blindly: Identify and treat the root cause (PCOS, hypothalamic dysfunction, etc.) rather than just adding progesterone.

  3. Don't ignore endometrial protection: Even if you're not trying to conceive, chronic anovulation with this low progesterone puts you at risk for endometrial pathology.

  4. Don't continue progesterone supplementation beyond 12 weeks of pregnancy: The evidence shows no benefit and potential theoretical harm 5.

Your next step should be consultation with a reproductive endocrinologist or gynecologist who can perform the comprehensive hormonal evaluation outlined above and develop a targeted treatment plan based on the underlying cause of your anovulation.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.